AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72
PLEURAL CARCINOSIS CONFIRMED BY ADJUVANT CYTOLOGICAL METHODS - A CASE-REPORT
Authors: MOTHERBY H ROSS B KUBE M GERMING U HEYLL A AUL C BRAUNSTEIN S GABBERT HE BOCKING A
Citation: H. Motherby et al., PLEURAL CARCINOSIS CONFIRMED BY ADJUVANT CYTOLOGICAL METHODS - A CASE-REPORT, Diagnostic cytopathology, 19(5), 1998, pp. 370-374
DYSHEMATOPOIESIS IN DE-NOVO ACUTE MYELOID-LEUKEMIA - CELL BIOLOGICAL FEATURES AND PROGNOSTIC-SIGNIFICANCE
Authors: MECKENSTOCK G AUL C HILDEBRANDT B HEYLL A GERMING U WEHMEIER A GIAGOUNIDIS A SUEDHOFF T BURK M SOEHNGEN D SCHNEIDER W
Citation: G. Meckenstock et al., DYSHEMATOPOIESIS IN DE-NOVO ACUTE MYELOID-LEUKEMIA - CELL BIOLOGICAL FEATURES AND PROGNOSTIC-SIGNIFICANCE, Leukemia & lymphoma, 29(5-6), 1998, pp. 523-531
PLASMA-LEVELS OF D-DIMER AND CIRCULATING ENDOTHELIAL ADHESION MOLECULES IN VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SUDHOFF T HEINS M SOHNGEN D LENZ V WEHMEIER A AUL C MECKENSTOCK G SCHNEIDER W REINAUER H HEYLL A
Citation: T. Sudhoff et al., PLASMA-LEVELS OF D-DIMER AND CIRCULATING ENDOTHELIAL ADHESION MOLECULES IN VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, European journal of haematology, 60(2), 1998, pp. 106-111
GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) MEDIATED MOBILIZATION OF LEUKEMIC-CELLS IN PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA EXPRESSING MYELOID ANTIGENS (MY+PH+ALL)
Authors: KOBBE G BAUSER U RIETH C HUNERLITURKOGLU A SOHNGEN D AIVADO M AUL C HEYLL A
Citation: G. Kobbe et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) MEDIATED MOBILIZATION OF LEUKEMIC-CELLS IN PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA EXPRESSING MYELOID ANTIGENS (MY+PH+ALL), American journal of hematology, 58(4), 1998, pp. 330-333
PATIENT-CONTROLLED VERSUS STAFF-CONTROLLED ANALGESIA WITH PETHIDINE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: ZUCKER TP FLESCHE CW GERMING U SCHROTER S WILLERS R WOLF HH HEYLL A
Citation: Tp. Zucker et al., PATIENT-CONTROLLED VERSUS STAFF-CONTROLLED ANALGESIA WITH PETHIDINE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Pain, 75(2-3), 1998, pp. 305-312
ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL GRAFTS FROM 2 NORMAL DONORS OVER THE AGE OF 70 YEARS
Authors: KOBBE G SOEHNGEN D SCHNEIDER P RIETH C BAUSER U FISCHER J WERNET P AUL C HEYLL A
Citation: G. Kobbe et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL GRAFTS FROM 2 NORMAL DONORS OVER THE AGE OF 70 YEARS, Bone marrow transplantation, 21, 1998, pp. 5-5
PRIMARY UNRELATED ALLOGRAFTING BY G-CSF MOBILIZED PBPC
Authors: FISCHER J FRICK M HERDA A KUSNIERZGLAZ CR HEYLL A WERNET P
Citation: J. Fischer et al., PRIMARY UNRELATED ALLOGRAFTING BY G-CSF MOBILIZED PBPC, Bone marrow transplantation, 21, 1998, pp. 45-45
BMT IN REFRACTORY OR RELAPSED ADULT ALL PATIENTS TREATED IN THE GERMAN MULTICENTER ALL STUDIES
Authors: ARNOLD R BUNJES D DEEG HJ EINSELE H FAUSER AA FINKE J HERTENSTEIN B HEYLL A KOLB HJ KOLBE K MARTIN H NIEDERWIESER D SCHAEFER UW SCHMITZ N SCHWERDTFEGER R SIEGERT W WANDT H ZANDER A GOEKBUGET N HOELZER D
Citation: R. Arnold et al., BMT IN REFRACTORY OR RELAPSED ADULT ALL PATIENTS TREATED IN THE GERMAN MULTICENTER ALL STUDIES, Bone marrow transplantation, 21, 1998, pp. 2-2
HIGH-DOSE IDARUBICIN ADDED TO CVB AS AN INTENSIFIED HIGH-DOSE-CHEMOTHERAPY PROTOCOL FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED MALIGNANT-LYMPHOMA
Authors: HUNERLITURKOGLU A KOBBE G SOHNGEN D BAUSER U SCHNEIDER P THIELE KP MINNING H SUDHOFF T MECKENSTOCK G STRUPP C NIEDERSTEHOLLENBERG A AUL C HEYLL A
Citation: A. Hunerliturkoglu et al., HIGH-DOSE IDARUBICIN ADDED TO CVB AS AN INTENSIFIED HIGH-DOSE-CHEMOTHERAPY PROTOCOL FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED MALIGNANT-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 589-589
HIGH-DOSE IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE FOR TREATMENT OFMULTIPLE-MYELOMA
Authors: SCHNEIDER P SOHNGEN D KOBBE G BAUSER U HUNERLITURKOGLU A HEYLL A AUL C
Citation: P. Schneider et al., HIGH-DOSE IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE FOR TREATMENT OFMULTIPLE-MYELOMA, Bone marrow transplantation, 21, 1998, pp. 707-707
PROBLEMS IN THE CLASSIFICATION OF CMML - DYSPLASTIC VERSUS PROLIFERATIVE TYPE
Authors: GERMING U GATTERMANN N MINNING H HEYLL A AUL C
Citation: U. Germing et al., PROBLEMS IN THE CLASSIFICATION OF CMML - DYSPLASTIC VERSUS PROLIFERATIVE TYPE, Leukemia research, 22(10), 1998, pp. 871-878
ANAPHYLACTIC REACTION TO LIPOSOMAL AMPHOTERICIN (AMBISOME)
Authors: SCHNEIDER P KLEIN RM DIETZE L SOHNGEN D LESCHKE M HEYLL A
Citation: P. Schneider et al., ANAPHYLACTIC REACTION TO LIPOSOMAL AMPHOTERICIN (AMBISOME), British Journal of Haematology, 102(4), 1998, pp. 1108-1109
IMMUNOPHENOTYPIC AND GENOTYPIC FEATURES, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOME OF ADULT PRO-B ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF THE GERMAN MULTICENTER TRIALS GMALL 03 87 AND 04/89/
Authors: LUDWIG WD RIEDER H BARTRAM CR HEINZE B SCHWARTZ S GASSMANN W LOFFLER H HOSSFELD D HEIL G HANDT S HEYLL A DIEDRICH H FISCHER K WEISS A VOLKERS B AYDEMIR U FONATSCH C GOKBUGET N THIEL E HOELZER D
Citation: Wd. Ludwig et al., IMMUNOPHENOTYPIC AND GENOTYPIC FEATURES, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOME OF ADULT PRO-B ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF THE GERMAN MULTICENTER TRIALS GMALL 03 87 AND 04/89/, Blood, 92(6), 1998, pp. 1898-1909
LARGE-VOLUME LEUKAPHERESIS MAXIMIZES THE PROGENITOR-CELL YIELD FOR ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR DONATION
Authors: KOBBE G SOEHNGEN D HEYLL A FISCHER J THIELE KP AUL C WERNET P
Citation: G. Kobbe et al., LARGE-VOLUME LEUKAPHERESIS MAXIMIZES THE PROGENITOR-CELL YIELD FOR ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR DONATION, Journal of hematotherapy, 6(2), 1997, pp. 125-131
PHARMACOKINETICS OF HIGH-DOSE CYTARABINE AND ITS DEAMINATION PRODUCT-A REAPPRAISAL
Authors: BURK M HEYLL A ARNING M VOLMER M FARTASH K SCHNEIDER W
Citation: M. Burk et al., PHARMACOKINETICS OF HIGH-DOSE CYTARABINE AND ITS DEAMINATION PRODUCT-A REAPPRAISAL, Leukemia & lymphoma, 27(3-4), 1997, pp. 321-327
ACUTE ACALCULOUS CHOLECYSTITIS COMPLICATING ORAL RECONTAMINATION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: KOBBE G HEYLL A ZODLER T SOHNGEN D AUL C THIELE KP GERMING U SCHNEIDER W
Citation: G. Kobbe et al., ACUTE ACALCULOUS CHOLECYSTITIS COMPLICATING ORAL RECONTAMINATION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Oncology Reports, 4(4), 1997, pp. 823-824
ACQUIRED FACTOR-VIII INHIBITORS IN NONHEMOPHILIC PATIENTS
Authors: SOHNGEN D SPECKER C BACH D KUNTZ BME BURK M AUL C KOBBE G HEYLL A HOLLMIG KA SCHNEIDER W
Citation: D. Sohngen et al., ACQUIRED FACTOR-VIII INHIBITORS IN NONHEMOPHILIC PATIENTS, Annals of hematology, 74(2), 1997, pp. 89-93
IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE - AN INTENSIFIED HIGH-DOSEREGIMEN FOR THE TREATMENT OF MYELOMA PATIENTS
Authors: HEYLL A SOHNGEN D KOBBE G SCHNEIDER P BAUSER U THIELE KP WEHMEIER A SUDHOFF T QUENZEL EM RIETH C WERNET P FISCHER J FRICK M AUL C
Citation: A. Heyll et al., IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE - AN INTENSIFIED HIGH-DOSEREGIMEN FOR THE TREATMENT OF MYELOMA PATIENTS, Leukemia, 11, 1997, pp. 32-34
RECURRENT REVERSIBLE NEPHROTIC SYNDROME DURING THERAPY WITH RECOMBINANT INTERFERON-ALPHA
Authors: AUL C MINNING H SUDHOFF T GATTERMANN N HEYLL A
Citation: C. Aul et al., RECURRENT REVERSIBLE NEPHROTIC SYNDROME DURING THERAPY WITH RECOMBINANT INTERFERON-ALPHA, American journal of hematology, 54(1), 1997, pp. 91-91
DOUBLE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION WITH RECOMBINANTTISSUE-PLASMINOGEN ACTIVATOR
Authors: SOHNGEN D BAUSER U BOOGEN C AUL C FRIELING T GERMING U SCHNEIDER P KOBBE G HEYLL A
Citation: D. Sohngen et al., DOUBLE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION WITH RECOMBINANTTISSUE-PLASMINOGEN ACTIVATOR, Thrombosis and haemostasis, 78(4), 1997, pp. 1299-1300
DECREASED INTERLEUKIN-10 AND INCREASED INTERFERON-GAMMA PRODUCTION INPATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: KORHOLZ D KUNST D HEMPEL L SOHNGEN D HEYLL A BONIG H GOBEL U ZINTL F BURDACH S
Citation: D. Korholz et al., DECREASED INTERLEUKIN-10 AND INCREASED INTERFERON-GAMMA PRODUCTION INPATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(7), 1997, pp. 691-695
EXTRACORPOREAL PHOTOPHERESIS IN THE TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: RICHTER HI STEGE H RUZICKA T SOEHNGEN D HEYLL A KRUTMANN J
Citation: Hi. Richter et al., EXTRACORPOREAL PHOTOPHERESIS IN THE TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE, Journal of the American Academy of Dermatology, 36(5), 1997, pp. 787-789
FATAL HYPERLEUKOCYTIC SYNDROME IN A PATIENT WITH CHRONIC MYELOMONOCYTIC LEUKEMIA
Authors: AUL C GATTERMANN N GERMING U SUDHOFF T HOLLMIG KA HEYLL A
Citation: C. Aul et al., FATAL HYPERLEUKOCYTIC SYNDROME IN A PATIENT WITH CHRONIC MYELOMONOCYTIC LEUKEMIA, Leukemia research, 21(3), 1997, pp. 249-253
PRIMARY UNRELATED G-CSF-MOBILIZED PBPC-TRANSPLANTS
Authors: FISCHER J KUSNIERZGLAZ CR ENCZMANN J KIESEL U KOGLER G HEYLL A WERNET P
Citation: J. Fischer et al., PRIMARY UNRELATED G-CSF-MOBILIZED PBPC-TRANSPLANTS, Blood, 90(10), 1997, pp. 481-481
LATE EVENTS IN AML - DATA FROM LONG-TERM OBSERVATION OF PATIENTS IN 2TRIALS STARTING IN 1981 AND 1985
Authors: BUCHNER T HIDDEMANN W WORMANN B LOFFLER H GASSMANN W HAFERLACH T FONATSCH C HOSSFELD D MASCHMEYER G LENGFELDER E AUL C HEYLL A LUDWIG WD SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., LATE EVENTS IN AML - DATA FROM LONG-TERM OBSERVATION OF PATIENTS IN 2TRIALS STARTING IN 1981 AND 1985, Blood, 90(10), 1997, pp. 2247-2247
Risultati: 1-25 | 26-50 | 51-72